Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

Not Applicable

Completed

• Conditions: Healthy
• Interventions: Dietary Supplement: L-arabinose and indigestible dextrin; Dietary Supplement: Placebo

• Registration Number: NCT01039662
• Lead Sponsor: Hiroshima University

Brief Summary

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on dietary glycemic index.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-12
• Study First Submitted: 2009-12-24
• Study First Submitted QC: 2009-12-24
• Study First Posted: 2009-12-25
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Status Verified: 2011-06
• Last Update Submitted: 2011-06-22
• Last Update Posted: 2011-06-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

• Healthy as based on medical history and physical examination
• BMI is less or equal to 30 kg/m2
• Willing not to serve as blood donor during the study
• Informed consent signed

Exclusion Criteria

• Impaired Glucose Tolerance
• Female subjects who are pregnant or nursing a child
• Participation in any clinical trial up to 90 days before Day 1 of this study
• Renal or hepatic dysfunction
• Heart disease
• Under medication

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Oolong tea containing L-arabinose and indigestible dextrin	L-arabinose and indigestible dextrin	-
Oolong tea	Placebo	-

Primary Outcome Measures

Name	Time	Method
Postprandial glucose level	2 hours

Trial Locations

Locations (1)

Hiroshima University; 🇯🇵 Hiroshima, Japan